| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/25/2012 | CN102329306A Biphenyl valine derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension |
| 01/25/2012 | CN102329304A Diazaspiro derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension |
| 01/25/2012 | CN102329303A Biphenyltetrazole derivative and application thereof to preparation of medicament for preventing and/or treating hypertension |
| 01/25/2012 | CN102329267A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 01/25/2012 | CN101781288B Preparation method of Pranlukast intermediate |
| 01/25/2012 | CN101456841B Amide derivative and medicine |
| 01/24/2012 | US8101778 Five-membered heterocycles useful as serine protease inhibitors |
| 01/24/2012 | US8101768 Cyclic amine compound and pest control agent |
| 01/24/2012 | US8101638 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/24/2012 | US8101636 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 01/24/2012 | US8101615 Chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, heart failure |
| 01/24/2012 | US8101608 Compounds and compositions as protein kinase inhibitors |
| 01/24/2012 | US8101290 Organic compound having electron-transporting and/or hole-blocking performance and its use and OLEDs comprising the compound |
| 01/24/2012 | CA2684447C Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/24/2012 | CA2677313C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 01/24/2012 | CA2524498C 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
| 01/24/2012 | CA2509159C Isophthalic acid derivatives |
| 01/24/2012 | CA2509090C Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 01/24/2012 | CA2509088C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/19/2012 | WO2012008564A1 Nitrogenated aromatic heterocyclic ring derivative |
| 01/19/2012 | WO2012008528A1 Pyrazole compound |
| 01/19/2012 | WO2012007861A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| 01/19/2012 | WO2011132051A3 Tricycle compounds as phosphodiesterase-10 inhibitors |
| 01/19/2012 | WO2011112766A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011103289A3 Imidazole-2, 4-dione inhibitors of casein kinase 1 |
| 01/19/2012 | US20120016132 Novel method for producing enaminocarbonyl compounds |
| 01/19/2012 | US20120015983 Synthesis and Novel Salt Forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine |
| 01/19/2012 | US20120015961 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity |
| 01/19/2012 | US20120015959 Heterocyclic compounds as autotaxin inhibitors |
| 01/19/2012 | US20120015958 1-(4-ureidobenzoyl)piperazine derivatives |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/19/2012 | US20120015936 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120015908 Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives |
| 01/19/2012 | US20120015907 Furopyridine compounds and uses thereof |
| 01/19/2012 | US20120014997 Aryl sulfonamides |
| 01/19/2012 | CA2805219A1 Pyrazole compound |
| 01/19/2012 | CA2801032A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| 01/18/2012 | EP2407451A1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/18/2012 | EP2406262A1 Prodrug forms of kinase inhibitors and their use in therapy |
| 01/18/2012 | EP2406253A1 Benzofuranyl derivatives used as glucokinase inhibitors |
| 01/18/2012 | EP2406252A1 Mineralocorticoid receptor antagonist and methods of use |
| 01/18/2012 | EP2406243A1 Benzofuran derivatives |
| 01/18/2012 | EP2406240A2 Inhibitors of beta-secretase |
| 01/18/2012 | EP2406226A1 Substituted nicotinamides as kcnq2/3 modulators |
| 01/18/2012 | EP2406220A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 01/18/2012 | EP2220076B1 Inhibitors of human immunodeficiency virus replication |
| 01/18/2012 | EP1992618B1 Polycyclic cinnamide derivative |
| 01/18/2012 | EP1713780B1 Novel inhibitors of glutaminyl cyclase |
| 01/18/2012 | EP1656373B1 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists |
| 01/18/2012 | EP1256574B1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 01/18/2012 | CN1976706B Inhibition of FGFR3 and treatment of multiple myeloma |
| 01/18/2012 | CN1950351B 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/18/2012 | CN102325767A 7-phenoxychroman carboxylic acid derivatives |
| 01/18/2012 | CN102325764A Pyrimidine indole derivatives for treating cancer |
| 01/18/2012 | CN102325754A Cyclic compound having hetero atom |
| 01/18/2012 | CN102325753A Carbazole carboxamide compounds useful as kinase inhibitors |
| 01/18/2012 | CN102325752A Carbazole and carboline kinase inhibitors |
| 01/18/2012 | CN102325751A Aromatic amine derivative and organic electroluminescent element |
| 01/18/2012 | CN102321081A Preparation method of substituted enaminocarbonyl compound used as insecticide and intermediate |
| 01/18/2012 | CN102321080A Doxazosin mesylate V form crystal, and preparation method and usage thereof |
| 01/18/2012 | CN102321079A (-) doxazosin mesylate crystal VI as well as preparation method and application thereof |
| 01/18/2012 | CN102321078A Doxazosin mesylate III form crystal, and preparation method and usage thereof |
| 01/18/2012 | CN102321077A Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 01/18/2012 | CN102321076A Preparation method of lapatinib intermediate and analogues thereof |
| 01/18/2012 | CN102321074A Indole ring-substituted pyrazole hydrazide derivative and preparation method and application thereof |
| 01/18/2012 | CN102321034A Sulfobenzodiazepine compound and application thereof used as medicament |
| 01/18/2012 | CN102321020A LXR receptor modulators |
| 01/18/2012 | CN102319549A Preparation method of acetal type dicationic surfactant |
| 01/18/2012 | CN101773806B Triglycidyl isocyanurate melting granulating technology and production line thereof |
| 01/18/2012 | CN101304969B Benzene derivative or salt thereof |
| 01/17/2012 | US8097734 Crystalline sodium atorvastatin |
| 01/17/2012 | US8097629 Dihydropyridinone derivatives |
| 01/17/2012 | US8097611 Sulfonyl-derivatives as novel or histone deacetylase |
| 01/17/2012 | CA2500873C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 01/17/2012 | CA2494846C Arylamides |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2470255C N4-acylcytosine nucleosides for treatment of viral infections |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/12/2012 | WO2012006203A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 01/12/2012 | WO2012005299A1 Ros tyrosine kinase inhibitor |
| 01/12/2012 | WO2012004765A2 Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics |
| 01/12/2012 | WO2012004722A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 01/12/2012 | WO2012004207A1 (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 01/12/2012 | WO2012003642A1 Fused tricyclic compounds and use thereof for treating viral diseases |
| 01/12/2012 | WO2011133751A3 Process of producing cycloalkylcarboxamido-indole compounds |
| 01/12/2012 | WO2011123678A3 Substituted benzo-pyrido-triazolo-diazepine compounds |
| 01/12/2012 | US20120010414 Glycine transporter inhibiting substances |
| 01/12/2012 | US20120010283 Modulation of anxiety through blockade of anandamide hydrolysis |
| 01/12/2012 | US20120010263 Acetylene derivatives having mglur 5 antagonistic activity |
| 01/12/2012 | US20120010250 Anthranilamide derivatives as pesticides |
| 01/12/2012 | US20120010248 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof |
| 01/12/2012 | US20120010247 Bicyclic compound |
| 01/12/2012 | US20120010222 Gyrase Inhibitors and Uses Thereof |
| 01/12/2012 | US20120010219 Salvinorin derivatives and uses thereof |
| 01/12/2012 | US20120010204 Phthalazinone Derivatives |
| 01/12/2012 | US20120010183 Chemical Compounds |
| 01/12/2012 | US20120009617 Zinc sensors for cellular imaging |